In recent years, pharmaceutical and medical products companies have been faced with a growing number of consumer protection and fraud claims, both by governmental agencies and civil complainants, often in the form of class actions. All too often pharmaceutical companies and other clients are confronted with government investigations and challenges running parallel to class actions and qui tam suits. When faced with these intense situations, Dykema attorneys knowledgeable in regulatory and administrative law team with our healthcare, government policy and litigation attorneys covering all the bases. We represent our clients in all aspects of these redundant proceedings, working closely with our clients to make this often harrowing experience bearable and short-lived.
- Defended Procter & Gamble in litigation that became known as the "Satanism Case" that arose from a false rumor that spread throughout Amway that claimed P&G was associated with the Church of Satan and P&G's reaction to the rumor; obtained summary judgment on a claim for damages exceeding $1 billion.
- Successfully defended clients in an AAA arbitration brought by investors seeking roughly $5 million in damages for fraud, breach of contract and RICO violations.
- Represented national drug chain in qui tam action relating to violation of Michigan Medicaid False Claims Act and Michigan Health Care False Claims Act.
- Represented an individual during the investigation arising out of a qui tam action filed under the federal civil False Claims Act of the alleged off label marketing of a drug for non-FDA approved uses.